As of Jul 01
| +0.01 / +0.26%|
The 4 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 13.50, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +254.33% increase from the last price of 3.81.
The current consensus among 4 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.